OCEANiC

A study on the effect of Osimertinib, with or without Adjuvant Chemotherapy, Guided by Tumour Next Generation Sequencing (NGS) Co-mutation Status and circulating tumour DNA (ctDNA) Detection on disease-free survival in Patients with Stage IIA-IIIA epidermal growth factor receptor (EGFR)-Mutant Non-Small Cell Lung Cancer Following Complete Surgical Resection

Enquire

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Lung cancer

Study Phase

Trial registration

Number: ACTRN12623000552684

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385294

GenesisCare Location(s)

Find out more Get directions

Principal Investigator(s)

Medical Oncologist

Prof. Nick Pavlakis

BSc MBBS MMed PhD FRACP

View Profile

Thank you for submitting.

We will be in touch within 24 hours

Form submission error

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.

First name *

Last name *

Email *

Phone *

+61

Postalcode *

State/territory *

What is the reason for enquiry?

How would you prefer to be contacted? *

Phone Email

By clicking “submit” below, you acknowledge we will use the information you are providing to contact you about your referral request. Refer to our Private Policy for more information about how we handle personal information.

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.

Disclaimer: